SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-145578
Filing Date
2023-05-16
Accepted
2023-05-16 06:09:01
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d478076d424b5.htm 424B5 122498
2 GRAPHIC g478076g22a22.jpg GRAPHIC 39612
3 GRAPHIC g478076g33a33.jpg GRAPHIC 31324
4 GRAPHIC g478076g44a44.jpg GRAPHIC 38146
5 GRAPHIC g478076g55a55.jpg GRAPHIC 27460
  Complete submission text file 0001193125-23-145578.txt   296379
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-271400 | Film No.: 23925492
SIC: 2836 Biological Products, (No Diagnostic Substances)